News

Sensing technologies for acquiring real-time, precise, and reliable data are becoming more and more important in the field of healthcare, to help monitor, treat and coach patients. Future Diagnostics Solutions is proud to be a partner in the TTW funded Biomonitor project aiming at the development of continuous monitoring sensors.

To expand the Business Development Team, we are looking for a motivated new colleague.

After last year’s successful edition we are proud to be organizing our second IVDR & Immunoassays Mini Symposium on Wednesday November 20th, 2019 from 9 am to 10.30 am at MEDICA.

We were proud to be a partner of SensUs. SensUs believes that collaboration and information sharing on a worldwide scale is very important for innovation in the field of biosensors.

The FDA warns that biotin may interfere with lab tests.

Biotin is a vitamin that can be found in (multi-vitamin) pills or supplements for hair, skin, and nail growth. More and more people take or consider taking these pills or supplements. However, this biotin can significantly interfere with certain laboratory test and may cause test results that are incorrect.

Accuspheres are formed by combining a suitable matrix with the component of interest. This solution (minimal of 50 μl) is dripped into liquid nitrogen followed by a freeze-drying process, which forms the stable sphere.

We wish our customers, colleagues, partners and other stakeholders the best of joy and cheer for Christmas and the coming year.

We are proud to announce that Future Diagnostics Solutions has now succesfully transitioned its Quality Management System to ISO 13485:2016. The scope of the approval is applicable to research, development, manufacturing, sales and distribution of in vitro diagnostic medical devices and accessories, including R&D services and contract manufacturing. Future Diagnostics is ISO 13485 certified since 2004.